Stephen M. Ansell, MD, PhD of Mayo Clinic discusses the abstracts and new data that were presented at the second oral session for ASCO-SITC. The research focused on mutations in tumor and how those affects patients’ responses to treatment. This was recorded ASCO-SITC Clinical Immuno-Oncology Symposium in Orlando, Florida.
Tumor Mutation, T-Cell Activity, Bowel Biology, and Circulating Molecules May Predict Treatment Response
